Medical Condition: Have been diagnosed with rheumatoid arthritis.
Screening period is up to 6 weeks.
Treatment period is about 52 weeks.
You will visit the study center at least 13 times for study assessments.
You will receive the study medication injection at the study center or self-administer it at home once every week.
You will take a study medication capsule twice a day at home.
You may have the opportunity to take part in a long-term extension study once you have completed the treatment period.
If you don't take part in the long-term extension study, you will visit the study center once for study assessments about 8 weeks after your last dose of study medication.
Age: 18 years or older
You must have swollen and painful joints despite taking one or two of the following csDMARDs for at least the past 12 weeks: methotrexate, hydroxychloroquine, chloroquine, sulfasalazine, leflunomide, bucillamine or iguratimod.
Please contact our office and speak to Gaby (916) 966-7452 for screening and study exclusions.
All study medications and study-related tests will be provided at no cost to you.